David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 59,481 shares at $38.17 ($2.5M) on 2020-11-11, disclosed to the SEC on 2020-11-12.
Open-market sale of $2.5M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.95 | 5,207 | $218K | 8.9% |
| 2 | $41.95 | 5,207 | $218K | 8.9% |
| 3 | $42.67 | 5,477 | $234K | 9.5% |
| 4 | $42.67 | 5,477 | $234K | 9.5% |
| 5 | $44.00 | 100 | $4K | 0.2% |
| 6 | $41.29 | 7,880 |
| $325K |
| 13.2% |
| 7 | $41.29 | 7,880 | $325K | 13.2% |
| 8 | $42.31 | 4,601 | $195K | 7.9% |
| 9 | $42.31 | 4,601 | $195K | 7.9% |
| 10 | $43.07 | 200 | $9K | 0.4% |
| 11 | $38.17 | 2,620 | $100K | 4.1% |
| 12 | $38.17 | 2,620 | $100K | 4.1% |
| 13 | $39.22 | 3,354 | $132K | 5.4% |
| 14 | $39.22 | 3,354 | $132K | 5.4% |
| 15 | $40.36 | 903 | $36K | 1.5% |
| Total | $41.31 avg | 59,481 | $2.5M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |